288 related articles for article (PubMed ID: 1359961)
1. Differential effects of neuroexcitatory amino acids on corticotropin-releasing hormone-41 and vasopressin release from rat hypothalamic explants.
Costa A; Yasin SA; Hucks D; Forsling ML; Besser GM; Grossman A
Endocrinology; 1992 Dec; 131(6):2595-602. PubMed ID: 1359961
[TBL] [Abstract][Full Text] [Related]
2. Involvement of neuroexcitatory amino acids in the control of gonadotropin-releasing hormone release from the hypothalamus of the adult male guinea pig: predominantly inhibitory action of N-methyl-D-aspartate-mediated neurotransmission and its reversal after orchidectomy.
Giri M; Kaufman JM
Endocrinology; 1995 Jun; 136(6):2404-7. PubMed ID: 7750461
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization.
Pittaluga A; Raiteri M
J Pharmacol Exp Ther; 1992 Jan; 260(1):232-7. PubMed ID: 1370540
[TBL] [Abstract][Full Text] [Related]
4. Pulsatile release of gonadotropin-releasing hormone from hypothalamic explants is restrained by blockade of N-methyl-D,L-aspartate receptors.
Bourguignon JP; Gerard A; Mathieu J; Simons J; Franchimont P
Endocrinology; 1989 Aug; 125(2):1090-6. PubMed ID: 2546737
[TBL] [Abstract][Full Text] [Related]
5. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
Verdoorn TA; Kleckner NW; Dingledine R
Mol Pharmacol; 1989 Mar; 35(3):360-8. PubMed ID: 2564633
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of noradrenaline release in human cerebral cortex mediated by N-methyl-D-aspartate (NMDA) and non-NMDA receptors.
Fink K; Schultheiss R; Göthert M
Br J Pharmacol; 1992 May; 106(1):67-72. PubMed ID: 1380384
[TBL] [Abstract][Full Text] [Related]
7. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
Patchev VK; Karalis K; Chrousos GP
Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936
[TBL] [Abstract][Full Text] [Related]
8. Direct activation of gonadotropin-releasing hormone secretion through different receptors to neuroexcitatory amino acids.
Bourguignon JP; Gérard A; Franchimont P
Neuroendocrinology; 1989 Apr; 49(4):402-8. PubMed ID: 2541362
[TBL] [Abstract][Full Text] [Related]
9. Excitatory amino acid-induced phosphoinositide hydrolysis in Müller glia.
López-Colomé AM; Ortega A; Romo-de-Vivar M
Glia; 1993 Oct; 9(2):127-35. PubMed ID: 7902338
[TBL] [Abstract][Full Text] [Related]
10. Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide.
Costa A; Nappi RE; Polatti F; Poma A; Grossman AB; Nappi G
Exp Neurol; 2000 Dec; 166(2):376-84. PubMed ID: 11085902
[TBL] [Abstract][Full Text] [Related]
11. Effect of excitatory amino acid on the hypothalamo-pituitary-adrenal axis in the rat during the stress-hyporesponsive period.
Chautard T; Boudouresque F; Guillaume V; Oliver C
Neuroendocrinology; 1993 Jan; 57(1):70-8. PubMed ID: 8097578
[TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate, kainate and quisqualate release endogenous adenosine from rat cortical slices.
Hoehn K; White TD
Neuroscience; 1990; 39(2):441-50. PubMed ID: 1982346
[TBL] [Abstract][Full Text] [Related]
13. Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro.
Donoso AO; López FJ; Negro-Vilar A
Endocrinology; 1990 Jan; 126(1):414-20. PubMed ID: 2152870
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate antagonists prevent kainate neurotoxicity in rat retinal ganglion cells in vitro.
Sucher NJ; Aizenman E; Lipton SA
J Neurosci; 1991 Apr; 11(4):966-71. PubMed ID: 1672708
[TBL] [Abstract][Full Text] [Related]
15. Glutamate and N-methyl-D-aspartate stimulate rat hypothalamic corticotropin-releasing factor secretion in vitro.
Joanny P; Steinberg J; Oliver C; Grino M
J Neuroendocrinol; 1997 Feb; 9(2):93-7. PubMed ID: 9041361
[TBL] [Abstract][Full Text] [Related]
16. 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus.
Blake JF; Yates RG; Brown MW; Collingridge GL
Br J Pharmacol; 1989 May; 97(1):71-6. PubMed ID: 2566354
[TBL] [Abstract][Full Text] [Related]
17. Release of 3H-noradrenaline by excitatory amino acids from rat mediobasal hypothalamus and the influence of aging.
Navarro CE; Cabrera RJ; Donoso AO
Brain Res Bull; 1994; 33(6):677-82. PubMed ID: 7910775
[TBL] [Abstract][Full Text] [Related]
18. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro.
Yasin SA; Costa A; Besser GM; Hucks D; Grossman A; Forsling ML
Endocrinology; 1993 Mar; 132(3):1329-36. PubMed ID: 8440190
[TBL] [Abstract][Full Text] [Related]
19. Augmentation by glycine and blockade by 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) of responses to excitatory amino acids in slices of rat neocortex.
Thomson AM
Neuroscience; 1990; 39(1):69-79. PubMed ID: 1982468
[TBL] [Abstract][Full Text] [Related]
20. Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials.
Randle JC; Guet T; Bobichon C; Moreau C; Curutchet P; Lambolez B; de Carvalho LP; Cordi A; Lepagnol JM
Mol Pharmacol; 1992 Feb; 41(2):337-45. PubMed ID: 1371583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
